BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simmonds NJ, Rampton DS. Inflammatory bowel disease--a radical view. Gut. 1993;34:865-868. [PMID: 8344570 DOI: 10.1136/gut.34.7.865] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Broekman MM, Bos C, Te Morsche RH, Hoentjen F, Roelofs HM, Peters WH, Wanten GJ, de Jong DJ. GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease. J Hum Genet 2014;59:575-80. [PMID: 25186055 DOI: 10.1038/jhg.2014.77] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
2 Nguyen TT, Trinh NT, Tran HN, Tran HT, Le PQ, Ngo DN, Tran-Van H, Van Vo T, Vong LB, Nagasaki Y. Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease. J Control Release 2021;331:515-24. [PMID: 33616078 DOI: 10.1016/j.jconrel.2020.10.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
3 Woo SG, Moon SJ, Kim SK, Kim TH, Lim HS, Yeon GH, Sung BH, Lee CH, Lee SG, Hwang JH, Lee DH. A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing. Biosens Bioelectron 2020;168:112523. [PMID: 32871497 DOI: 10.1016/j.bios.2020.112523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
4 Tran CD, Ball JM, Sundar S, Coyle P, Howarth GS. The role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Dig Dis Sci. 2007;52:2113-2121. [PMID: 17410436 DOI: 10.1007/s10620-007-9765-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
5 Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol. 1999;94:704-712. [PMID: 10086655 DOI: 10.1111/j.1572-0241.1999.00940.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 3.1] [Reference Citation Analysis]
6 Hosseini-tabatabaei A, Esmaily H, Rahimian R, Khorasani R, Baeeri M, Barazesh-morgani A, Sari-aslani F, Abdollahi M. Benefit of nicorandil using an immunologic murine model of experimental colitis. Open Life Sciences 2009;4:74-85. [DOI: 10.2478/s11535-008-0047-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996;313 ( Pt 1):17-29. [PMID: 8546679 DOI: 10.1042/bj3130017] [Cited by in Crossref: 1490] [Cited by in F6Publishing: 1254] [Article Influence: 59.6] [Reference Citation Analysis]
8 Varga C, Laszlo F, Fritz P, Cavicchi M, Lamarque D, Horvath K, Posa A, Berko A, Whittle BJ. Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat. Eur J Pharmacol 2007;561:164-71. [PMID: 17292349 DOI: 10.1016/j.ejphar.2006.12.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
9 Chatterjee A, Yasmin T, Bagchi D, Stohs SJ. Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin. Mol Cell Biochem. 2004;265:19-26. [PMID: 15543930 DOI: 10.1023/b:mcbi.0000044310.92444.ec] [Cited by in Crossref: 69] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
10 Kasımay Ö, Güzel E, Gemici A, Abdyli A, Sulovari A, Ercan F, Yeğen BÇ. Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise: Exercise attenuates severity of colitis. Experimental Physiology 2006;91:897-906. [DOI: 10.1113/expphysiol.2006.034439] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
11 Zhou Z, Chen X, Sheng H, Shen X, Sun X, Yan Y, Wang J, Yuan Q. Engineering probiotics as living diagnostics and therapeutics for improving human health. Microb Cell Fact 2020;19:56. [PMID: 32131831 DOI: 10.1186/s12934-020-01318-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 20.0] [Reference Citation Analysis]
12 Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther. 2002;16:197-205. [PMID: 11860402 DOI: 10.1046/j.1365-2036.2002.01157.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
13 Satoyoshi K, Akita Y, Nozu F, Yoshikawa N, Mitamura K. Hemodynamics in the colonic mucosa of rats with dextran sulfate-induced colitis in the early phase. J Gastroenterol 1996;31:512-7. [DOI: 10.1007/bf02355050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Farrell RJ, Banerjee S, Peppercorn MA. Recent advances in inflammatory bowel disease. Crit Rev Clin Lab Sci 2001;38:33-108. [PMID: 11256517 DOI: 10.1080/20014091084173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
15 Elton E, Hanauer SB. Review article: The medical management of Crohn's disease. Alimentary Pharmacology & Therapeutics 1996;10:1-22. [DOI: 10.1111/j.1365-2036.1996.tb00173.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
16 Ghafari H, Yasa N, Mohammadirad A, Dehghan G, Zamani MJ, Nikfar S, Khorasani R, Minaie B, Abdollahi M. Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Hum Exp Toxicol. 2006;25:325-332. [PMID: 16866190 DOI: 10.1191/0960327105ht626oa] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
17 Vong LB, Mo J, Abrahamsson B, Nagasaki Y. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose–response efficacy. Journal of Controlled Release 2015;210:19-25. [DOI: 10.1016/j.jconrel.2015.05.275] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
18 Vasina V, Broccoli M, Ursino MG, Canistro D, Valgimigli L, Soleti A, Paolini M, De Ponti F. Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. World J Gastroenterol. 2010;16:3642-3650. [PMID: 20677336 DOI: 10.3748/wjg.v16.i29.3642] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
19 Stohs SJ. The Role of Free Radicals in Toxicity and Disease. Journal of Basic and Clinical Physiology and Pharmacology 1995;6. [DOI: 10.1515/jbcpp.1995.6.3-4.205] [Cited by in Crossref: 137] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
20 Shibata H, Kimura-takagi I, Nagaoka M, Hashimoto S, Aiyama R, Iha M, Ueyama S, Yokokura T. Properties of fucoidan from Cladosiphon okamuranus tokida in gastric mucosal protection. BioFactors 2000;11:235-45. [DOI: 10.1002/biof.5520110402] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
21 Okayama M, Tsubouchi R, Kato S, Takeuchi K. Protective effect of lafutidine, a novel histamine H2-receptor antagonist, on dextran sulfate sodium-induced colonic inflammation through capsaicin-sensitive afferent neurons in rats. Dig Dis Sci. 2004;49:1696-1704. [PMID: 15573930 DOI: 10.1023/b:ddas.0000043389.96490.76] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
22 Duncan H, Swanx C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA, Strange RC. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clinica Chimica Acta 1995;240:53-61. [DOI: 10.1016/0009-8981(95)06127-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
23 Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma 1995;19:43-93. [PMID: 8574171 DOI: 10.3109/10428199509059662] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 4.4] [Reference Citation Analysis]
24 Porter SN, Howarth GS, Butler RN. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats. Scand J Gastroenterol. 1998;33:967-974. [PMID: 9759954 DOI: 10.1080/003655298750027001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
25 Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A. 2001;64:213-222. [PMID: 11594700 DOI: 10.1080/15287390152543690] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 3.5] [Reference Citation Analysis]
26 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329:eohsph>2.0.co;2] [Reference Citation Analysis]
27 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
28 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
29 Fukuda Y, Tao Y, Tomita T, Hori K, Fukunaga K, Noguchi T, Hayashi T, Shimoyama T, Tahahashi R. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scandinavian Journal of Gastroenterology 2009;41:1183-9. [DOI: 10.1080/00365520600575704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Hanauer SB, Schulman MI. NEW THERAPEUTIC APPROACHES. Gastroenterology Clinics of North America 1995;24:523-40. [DOI: 10.1016/s0889-8553(21)00209-0] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
31 Geerling BJ, Badart-Smook A, van Deursen C, van Houwelingen AC, Russel MG, Stockbrügger RW, Brummer RJ. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis. 2000;6:77-84. [PMID: 10833065 DOI: 10.1097/00054725-200005000-00002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
32 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones 2003;8:329-34. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329:eohsph>2.0.co;2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
33 Fang S, Christensen J. Manganese superoxide dismutase and reduced nicotinamide adenine dinucleotide diaphorase colocalize in the rat gut. Gastroenterology 1995;109:1429-36. [DOI: 10.1016/0016-5085(95)90627-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
34 Langhorst J, Frede A, Knott M, Pastille E, Buer J, Dobos GJ, Westendorf AM. Distinct Kinetics in the Frequency of Peripheral CD4+ T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal. PLoS One. 2014;9:e104257. [PMID: 25144293 DOI: 10.1371/journal.pone.0104257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Vong LB, Tomita T, Yoshitomi T, Matsui H, Nagasaki Y. An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice. Gastroenterology 2012;143:1027-1036.e3. [DOI: 10.1053/j.gastro.2012.06.043] [Cited by in Crossref: 117] [Cited by in F6Publishing: 90] [Article Influence: 13.0] [Reference Citation Analysis]
36 Mittal RD, Manchanda PK, Bid HK, Ghoshal UC. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. J Gastroenterol Hepatol. 2007;22:920-924. [PMID: 17565649 DOI: 10.1111/j.1440-1746.2006.04538.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
37 Li S, Xie A, Li H, Zou X, Zhang Q. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease. J Control Release 2019;316:66-78. [PMID: 31682913 DOI: 10.1016/j.jconrel.2019.10.054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
38 Chatterjee A, Yasmin T, Bagchi D, Stohs SJ. The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori. Mol Cell Biochem 2003;243:29-35. [PMID: 12619886 DOI: 10.1023/a:1021649427988] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
39 Reimund JM, Allison AC, Muller CD, Dumont S, Kenney JS, Baumann R, Duclos B, Poindron P. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1998;28:145-50. [PMID: 9541129 DOI: 10.1046/j.1365-2362.1998.00257.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
40 Järnerot G, Ström M, Danielsson A, Kilander A, Lööf L, Hultcrantz R, Löfberg R, Florén C, Nilsson A, Broström O. Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis. Aliment Pharmacol Ther. 2000;14:1159-1162. [PMID: 10971232 DOI: 10.1046/j.1365-2036.2000.00821.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
41 J. A. Dykens, T. J. Baginski. Urinary 8-Hydroxydeoxyguanosine Excretion as a Non-Invasive Marker of Neutrophil Activation in Animal Models of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 2009;33:628-36. [DOI: 10.1080/00365529850171918] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
42 Håkansson Å, Bränning C, Adawi D, Molin G, Nyman M, Jeppsson B, Ahrné S. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scandinavian Journal of Gastroenterology 2009;44:1213-25. [DOI: 10.1080/00365520903171268] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
43 Ebrahimi F, Esmaily H, Baeeri M, Mohammadirad A, Fallah S, Abdollahi M. Molecular evidences on the benefit of N-acetylcysteine in experimental colitis. Open Life Sciences 2008;3:135-42. [DOI: 10.2478/s11535-008-0005-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
44 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329: eohsph>2.0.co; 2] [Reference Citation Analysis]
45 Pélissier MA, Muller C, Hill M, Morfin R. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat. Steroids 2006;71:240-8. [PMID: 16371229 DOI: 10.1016/j.steroids.2005.10.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
46 Okayama M, Hayashi S, Aoi Y, Nishio H, Kato S, Takeuchi K. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats. Dig Dis Sci. 2007;52:2095-2103. [PMID: 17429720 DOI: 10.1007/s10620-006-9597-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
47 Rampton DS, Phil D. New treatments for inflammatory bowel disease. World J Gastroenterol 1998;4:369-76. [PMID: 11819324 DOI: 10.3748/wjg.v4.i5.369] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
48 Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci. 2015;60:1396-1405. [PMID: 25407806 DOI: 10.1007/s10620-014-3437-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
49 Whittle BJ, Varga C. New light on the anti-colitic actions of therapeutic aminosalicylates: the role of heme oxygenase. Pharmacol Rep. 2010;62:548-556. [PMID: 20631420 DOI: 10.1016/s1734-1140(10)70312-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
50 Blackburn AC, Doe WF, Buffinton GD. Salicylate Hydroxylation as an Indicator of Hydroxyl Radical Generation in Dextran Sulfate-Induced Colitis. Free Radical Biology and Medicine 1998;25:305-13. [DOI: 10.1016/s0891-5849(98)00068-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
51 Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci. 1998;43:1088-1095. [PMID: 9590426 DOI: 10.1023/a:1018899222258] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
52 Trebble TM, Stroud MA, Wootton SA, Calder PC, Fine DR, Mullee MA, Moniz C, Arden NK. High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial. Br J Nutr. 2005;94:253-261. [PMID: 16115360 DOI: 10.1079/bjn20051466] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
53 Ardite E, Sans M, Panés J, Romero FJ, Piqué JM, Fernández-Checa JC. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest. 2000;80:735-744. [PMID: 10830784 DOI: 10.1038/labinvest.3780077] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 3.7] [Reference Citation Analysis]
54 Reimund JM, Hirth C, Koehl C, Baumann R, Duclos B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin Nutr 2000;19:43-8. [PMID: 10700533 DOI: 10.1054/clnu.1999.0073] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
55 Xing J, Sun J, You H, Lv J, Sun J, Dong Y. Anti-inflammatory effect of 3,4-oxo-isopropylidene-shikimic acid on acetic acid-induced colitis in rats. Inflammation 2012;35:1872-9. [PMID: 22829139 DOI: 10.1007/s10753-012-9509-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
56 Iwaya H, Kashiwaya M, Shinoki A, Lee J, Hayashi K, Hara H, Ishizuka S. Marginal Zinc Deficiency Exacerbates Experimental Colitis Induced by Dextran Sulfate Sodium in Rats. The Journal of Nutrition 2011;141:1077-82. [DOI: 10.3945/jn.111.138180] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
57 Gombert S, Rhein M, Winterpacht A, Münster T, Hillemacher T, Leffler A, Frieling H. Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn's disease. Clin Epigenetics 2019;12:1. [PMID: 31892361 DOI: 10.1186/s13148-019-0796-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
58 Moghadasian MH, Godin DV. Gender-related regional antioxidant profiles in the gastrointestinal tract of the rat. Mol Cell Biochem 1996;155:43-9. [DOI: 10.1007/bf00714332] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Sturniolo GC, Mestriner C, Lecis PE, D'Odorico A, Venturi C, Irato P, Cecchetto A, Tropea A, Longo G, D'Inca R. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol. 1998;33:644-649. [PMID: 9669638 DOI: 10.1080/00365529850171936] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
60 Madesh M, Balasubramanian KA. Inhibition by Aminosalicylates of Phosphatidic Acid Formation Induced by Superoxide, Calcium or Spermine in Enterocyte Mitochondria. Biochemical Pharmacology 1998;55:1489-95. [DOI: 10.1016/s0006-2952(97)00642-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Rampton DS, Collins CE. Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications. Aliment Pharmacol Ther. 1993;7:357-367. [PMID: 8218751 DOI: 10.1111/j.1365-2036.1993.tb00109.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
62 Nakhai LA, Mohammadirad A, Yasa N, Minaie B, Nikfar S, Ghazanfari G, Zamani MJ, Dehghan G, Jamshidi H, Boushehri VS. Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel Disease. Evid Based Complement Alternat Med. 2007;4:43-50. [PMID: 17342240 DOI: 10.1093/ecam/nel051] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
63 Dodda D, Chhajed R, Mishra J, Padhy M. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin. Indian J Pharmacol. 2014;46:286-291. [PMID: 24987175 DOI: 10.4103/0253-7613.132160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
64 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329] [Reference Citation Analysis]
65 Murthy SNS, Fondacaro JD, Murthy NS, Cooper HS, Bolkenius F. Beneficial effect of MDL 73404 in dextran sulfate-mediated murine colitis. Agents and Actions 1994;41:C233-4. [DOI: 10.1007/bf01987650] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
66 Zhang QB, Nakashabendi IM, Mokhashi MS, Dawodu JB, Gemmell CG, Russell RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut. 1996;38:841-845. [PMID: 8984021 DOI: 10.1136/gut.38.6.841] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
67 Frommel TO, Yong S, Zarling EJ. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol. 1999;94:178-182. [PMID: 9934751 DOI: 10.1111/j.1572-0241.1999.00792.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
68 Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005;22:1097-105. [DOI: 10.1111/j.1365-2036.2005.02700.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
69 Bagchi D, Bhattacharya G, Stohs SJ. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res. 1996;24:439-450. [PMID: 8804987 DOI: 10.3109/10715769609088043] [Cited by in Crossref: 100] [Cited by in F6Publishing: 100] [Article Influence: 4.0] [Reference Citation Analysis]
70 Yoshitomi T, Nagasaki Y. Development of silica-containing redox nanoparticles for medical applications. Biomater Sci 2015;3:810-5. [DOI: 10.1039/c5bm00057b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Esmaily H, Hosseini-tabatabaei A, Rahimian R, Khorasani R, Baeeri M, Barazesh-morgani A, Yasa N, Khademi Y, Abdollahi M. On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells. Open Life Sciences 2009;4:204-13. [DOI: 10.2478/s11535-008-0053-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Okayama M, Tsubouchi R, Nishio H, Kato S, Takeuchi K. Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis. Digestion. 2004;70:240-249. [PMID: 15687726 DOI: 10.1159/000083716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
73 Crotty B. Ulcerative colitis and xenobiotic metabolism. The Lancet 1994;343:35-8. [DOI: 10.1016/s0140-6736(94)90882-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
74 Kang OH, Kim DK, Cai XF, Kim YH, Lee YM. Attenuation of experimental murine colitis by acanthoic acid from Acanthopanax koreanum. Arch Pharm Res 2010;33:87-93. [PMID: 20191349 DOI: 10.1007/s12272-010-2230-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
75 Pilarczyk-Zurek M, Chmielarczyk A, Gosiewski T, Tomusiak A, Adamski P, Zwolinska-Wcislo M, Mach T, Heczko PB, Strus M. Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis. BMC Gastroenterol. 2013;13:61. [PMID: 23566070 DOI: 10.1186/1471-230x-13-61] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
76 Tsubouchi R, Hayashi S, Aoi Y, Nishio H, Terashima S, Kato S, Takeuchi K. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats. Digestion. 2006;74:91-100. [PMID: 17143008 DOI: 10.1159/000097657] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
77 Chen Y, Chen Y, Liu WL, Zhou TH, Cai JT, Du Q, Wang LJ, Wu JG, Si JM. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats. J Gastroenterol Hepatol 2009;24:912-9. [PMID: 19220658 DOI: 10.1111/j.1440-1746.2008.05721.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
78 Trebble TM. Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants. Proc Nutr Soc 2005;64:183-91. [DOI: 10.1079/pns2005419] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
79 Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 1999;5:253-61. [PMID: 10579118 DOI: 10.1097/00054725-199911000-00003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
80 Kaya E, Gür ES, Ozgüç H, Bayer A, Tokyay R. L-glutamine enemas attenuate mucosal injury in experimental colitis. Dis Colon Rectum. 1999;42:1209-1215. [PMID: 10496564 DOI: 10.1007/bf02238577] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Biagioni C, Favilli F, Catarzi S, Marcucci T, Fazi M, Tonelli F, Vincenzini MT, Iantomasi T. Redox state and O2*- production in neutrophils of Crohn's disease patients. Exp Biol Med (Maywood) 2006;231:186-95. [PMID: 16446495 DOI: 10.1177/153537020623100209] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
82 Pikarsky A, Zmora O, Wexner SD. Immunosuppressants and operation in ulcerative colitis1 1No competing interests declared.Invited lecture at the American College of Surgeons 86th Annual Clinical Congress, Chicago, IL, October 2000. Journal of the American College of Surgeons 2002;195:251-60. [DOI: 10.1016/s1072-7515(02)01227-9] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
83 Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004;19:521-527. [PMID: 14987320 DOI: 10.1111/j.1365-2036.2004.01874.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
84 Zhang Q, Tao H, Lin Y, Hu Y, An H, Zhang D, Feng S, Hu H, Wang R, Li X, Zhang J. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Biomaterials 2016;105:206-21. [DOI: 10.1016/j.biomaterials.2016.08.010] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 17.6] [Reference Citation Analysis]
85 Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. BioFactors 2007;31:191-200. [DOI: 10.1002/biof.5520310306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
86 Geerling BJ. The Relation between Antioxidant Status and Alterations in Fatty Acid Profile in Patients with Crohn Disease and Controls. Scandinavian Journal of Gastroenterology 2009;34:1108-16. [DOI: 10.1080/003655299750024913] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
87 Sasaki M, Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr. 2007;40:1-12. [PMID: 18437208 DOI: 10.3164/jcbn.40.1] [Cited by in Crossref: 113] [Cited by in F6Publishing: 85] [Article Influence: 11.3] [Reference Citation Analysis]
88 Yoshitomi T, Nagasaki Y. Reactive Oxygen Species-Scavenging Nanomedicines for the Treatment of Oxidative Stress Injuries. Adv Healthcare Mater 2014;3:1149-61. [DOI: 10.1002/adhm.201300576] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
89 Pilarczyk-Zurek M, Strus M, Adamski P, Heczko PB. The dual role of Escherichia coli in the course of ulcerative colitis. BMC Gastroenterol 2016;16:128. [PMID: 27724868 DOI: 10.1186/s12876-016-0540-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
90 Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, Chatterjee A, Stohs SJ. Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig Dis Sci. 2002;47:1405-1412. [PMID: 12064819 DOI: 10.1023/a:1015399204069] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
91 Akcan A, Muhtaroglu S, Akgun H, Akyildiz H, Kucuk C, Sozuer E, Yurci A, Yilmaz N. Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats. World J Gastroenterol. 2008;14:1222-1230. [PMID: 18300348 DOI: 10.3748/wjg.14.1222] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
92 Noa M, Más R, Carbajal D, Valdés S. Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses. Pharmacol Res 2000;41:391-5. [PMID: 10704261 DOI: 10.1006/phrs.1999.0596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
93 Tassou C. Herbs, spices and gut health. Handbook of Herbs and Spices. Elsevier; 2006. pp. 151-76. [DOI: 10.1533/9781845691717.2.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Vong LB, Yoshitomi T, Morikawa K, Saito S, Matsui H, Nagasaki Y. Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis. J Gastroenterol 2014;49:806-13. [DOI: 10.1007/s00535-013-0836-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
95 Alagozlu H, Gorgul A, Bilgihan A, Tuncer C, Unal S. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Clinics and Research in Hepatology and Gastroenterology 2013;37:80-5. [DOI: 10.1016/j.clinre.2012.03.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
96 Riglar DT, Giessen TW, Baym M, Kerns SJ, Niederhuber MJ, Bronson RT, Kotula JW, Gerber GK, Way JC, Silver PA. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat Biotechnol 2017;35:653-8. [PMID: 28553941 DOI: 10.1038/nbt.3879] [Cited by in Crossref: 157] [Cited by in F6Publishing: 116] [Article Influence: 39.3] [Reference Citation Analysis]
97 Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000;14:1163-8. [PMID: 10971233 DOI: 10.1046/j.1365-2036.2000.00828.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
98 Trebble TM, Arden NK, Wootton SA, Calder PC, Mullee MA, Fine DR, Stroud MA. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. The American Journal of Clinical Nutrition 2004;80:1137-44. [DOI: 10.1093/ajcn/80.5.1137] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
99 Klotz U, Hoensch H, Schütz T, Beaune P, Zanger U, Bode JC, Fritz P. Expression of intestinal drug-metabolizing enzymes in patients with chronic inflammatory bowel disease. Current Therapeutic Research 1998;59:556-63. [DOI: 10.1016/s0011-393x(98)85095-9] [Cited by in Crossref: 13] [Article Influence: 0.6] [Reference Citation Analysis]
100 Loguercio C, D'argenio G, Cave MD, Cosenza V, Valle ND, Mazzacca G, Blanco CDV. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Digest Dis Sci 1996;41:1204-11. [DOI: 10.1007/bf02088238] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]